The term 'differentiation' is used in biology and pathology to describe the qualitative changes involved in the process of cell specialisation. The term is not defined in this book, which purports to be a monograph on the biology and clinical implications of differentiation in lung cancer. What the volume is, in fact, is a diverse collection of essays on a whole range of biological and clinical aspects of pulmonary neoplasia ranging from the role of the extracellular matrix in cell differentiation to an evaluation of population-based screening for the early detection of lung cancer. Some chapters (for example those on the epidermal growth factor receptor and on small-cell lung cancer antigens) are useful, well written and up to date, but the book suffers badly from a lack of direction and there are some glaring omissions. A most striking example is a complete lack of discussion of lung tumour histological classification, which is based entirely on morphological assessment of cell differentiation. The WHO classification of lung cancer is not even reproduced in tabular form. Other areas poorly covered include non-small-cell lung cancer differentiation markers (involucrin is referred to only once for example) and, in the clinical section, the role of surgical resection in the various histological subtypes of lung cancer.
An introductory chapter providing an overview of the biology of differentiation and the particular problems of lung cancer might have addressed some of these deficiencies.
Overall, therefore, the book is poorly edited and does not adequately cover the remit suggested in its title. It organised and reported on a series of well-thought-out logical trials in the area of head and neck cancers, including cancers of the mouth. At least three of his trials have reached the giddy heights of publication in the New England Journal of Medicine, and he was the first to use the extremely costeffective model of successfully treated lung and head and neck cancer patients for testing potential chemopreventive agents. He argued persuasively that the biggest risk factor for lung cancer is previous lung cancer, just as is the case for contralateral breast cancer following breast cancer. He was also the first to report that mortality and second smokingrelated cancers in the aerodigestive tract are legitimate endpoints for this kind of study. The recent clinical trial from the Royal Marsden by Powles et al. is presented in embryo form. The full report has now been published elsewhere.
The main drawback with this book is that it is based on a conference 21 years ago and there is still no real evidence that scientists and clinicians outside the authorship of this book have taken up the standard and followed in the crusade.
There have been a number of meetings on chemoprevention in the last 3 or 4 years, and sadly it tends to be the same faces and the same presentations given at each of them. It is not surprising, therefore, to find some of these articles in different forms in other symposia proceedings. Overall, however, it is a nicely produced book, and for a newcomer to the area of chemoprevention a comprehensive introduction to the key issues and the key players. Carcinogenicity testing is a vexed topic for many reasons. This book, however, concentrates on the test itself, its validity and prospects for improvement. There remains a general consensus that carcinogens fall into two main categories -agents that are either genotoxic or nongenotoxic -and currently both are tested in laboratory animals. This is unavoidable, partly because of the lack of adequate substitutes and especially because of pressures from regulatory bodies. Ironically, these same pressures have led to a situation in which the quality of the result can be compromised. Essentially, the problem has arisen through expectations that have been placed upon animal tests, giving them the status of a bioassay, and over a period this had led to unjustified assumptions concerning the meaning of the results. It has always been evident to the critical observer that the animal can contribute much towards an understanding of mechanisms of carcinogenesis, a point made clearly by one of the contributors, but that it can never be a truly adequate bioassay because of the variable natures of both the initiating stimuli and the ultimate biological end points. This book takes a hard look at the realities of the use of animals in carcinogenicity testing. In doing so it questions the validity of the conclusions, defines the problems and seeks ways towards improvements for the future.
Essentially, the book can be divided into four sections, dealing with the issues involved, how study design can be improved, decision-making and indications of the way forward. They are variable in quality, but all contribute valuable and interesting insights into an area where science is primarily driven by economic and regulatory pressures. The first section opens with a general review of mechanisms in carcinogenesis, which presents the background for the conclusion that there are a variety of relatively reliable tests for
